Xconomy Awards • Enter Now →
Founder and Managing Director of DEV
President & CEO, Indiana Biosciences Research Institute
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Founder and CEO of Brooks Bell Inc.
Managing Director, D.E. Shaw and Co., L.P.
Partner, Third Rock Ventures
Founder, Young Inventors
April 8, 2019 · Boston
May 21, 2019 · Boston
May 29, 2019 · San Diego
Waltham, MA-based Synchroneuron is developing a drug for tardive dyskinesia.
Sponsored · Whitepaper
Remain compliant and ensure optimal productivity
Xconomy Insight · Special Report
Get advice from the experts to help your biotech startup succeed
Implementing electronic solutions for risk mitigation
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2019, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.